ArticlePharmacotherapy2026

Genotype Differences and Hydroxyurea Utilization Among Adults With Moderate to Severe Sickle Cell Disease.

Siang-Hao Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.